Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonspecific skin and microbial components is a pharmacological designation for the collective biological structures—such as cell membranes, cytoplasmic proteins, and nucleic acids—that serve as the site of action for broad-spectrum topical antiseptics and disinfectants (Bigliardi et al., 2017). Unlike traditional therapeutic targets that involve specific binding to a single protein or receptor, these components are affected through generalized chemical and physical processes (Lim & Kam, 2008). Common mechanisms include the denaturation of proteins, the dissolution of lipid membranes, and the oxidation of cellular constituents, which lead to rapid microbial death (Finnegan et al., 2010). This target is primarily relevant in the context of preventing and treating localized infections, preparing skin for surgical procedures, and managing chronic wounds (Boyce & Pittet, 2002). While highly effective against a diverse range of pathogens, the nonspecific nature of these interactions can also lead to host tissue irritation or impaired healing if the agents are used at cytotoxic concentrations (Manganyi & Ateba, 2020).
Drugs targeting these components act through broad-spectrum, non-selective mechanisms such as protein denaturation, lipid membrane disruption, and oxidative damage to cellular structures (Bigliardi et al., 2017; Lim & Kam, 2008).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nonspecific skin and microbial components.